All patients included in the analysis had preoperative global LV dysfunction (LV ejection fraction (EF) <40%) and significantly enlarged LV (end-systolic volume index (ESVI)
urgical treatment of congestive heart failure associated with myocardial infarction (MI) is attracting much attention because its prognosis is still poor despite recent improvements in medical treatment. 1 Post-MI left ventricular (LV) remodeling is characterized by chamber dilatation and abnormal geometric change, which leads to heart failure progressing to ischemic cardiomyopathy. Heart transplantation is widely accepted as the optimal surgical therapy for heart failure patients, including those associated with ischemic etiology, but unfortunately transplantation is limited by the lack of donors and many exclusion criteria such as age and end-organ dysfunction. As an alternative surgical therapy, Dor at el introduced endoventricular circular patch plasty for patients with ischemic cardiomyopathy that has developed after a large anteroseptal MI. 2 Several modifications of LV restoration (LVR) have been proposed and some retrospective data, including largescale studies, have shown safety and efficacy in terms of survival benefit and LV functional recovery. 3, 4 Moreover, there is an ongoing multicenter, randomized, international trial (Surgical Treatment for Ischemic Heart Failure trial) to elucidate the real benefits of LVR. 5 However, there are only limited data about the long-term results of LVR in Japan. Furthermore, because of a specific situation related to the severely limited supply of organ donors and the limited availability of cardiac support devices, such as the ventricular assist system, 6 we have adopted liberal inclusion criteria for LVR, even for critically ill patients who are generally treated with mechanical circulatory support and subsequent heart transplantation. 7 Consequently, it is meaningful to examine our own experiences of LVR.
We conducted a multicenter retrospective study to analyze the long-term outcomes of LVR and examine its efficacy and limitations. >60 ml/m 2 ) related to previous anteroseptal MI. LVR was indicated for dyskinetic or akinetic anteroseptal myocardial scarring in all patients. Of the patients, 50 (68.5%) were in New York Heart Association (NYHA) functional class III or IV; 10 patients (13.9%) had ongoing cardiogenic shock and required emergency operations. Patients' preoperative characteristics are described in Table 1 .
Operations
Operative types are shown in Table 2 . All operations were performed with conventional cardiopulmonary bypass. Antegrade and retrograde cold blood cardioplegia were used for myocardial protection when required. Various techniques were employed for LVR. The type of LVR was the Dor-type procedure, with a purse string suture at the transitional zone (ie, Fontan stitch) 2 in 49 (68.1%), septal anterior ventricular exclusion (SAVE) 8 in 12 (16.7%), and overlapping procedure 9 in 11 (15.3%).The exclusion area was precisely determined on the basis of preoperative assessment of LV wall motion and myocardial viability, and intraoperative inspection of the infarcted zone. The choice of procedures mostly depended on the surgeon's preference. Technical details are described elsewhere. 2, 8, 9 In any case, the anteroseptal transmural scar was excluded as much as possible. Simultaneous coronary artery bypass grafting (CABG) was performed in 55 patients (76.4%), with a mean of 2.0±1.7 distal anastomoses. Patients who did not undergo CABG had been already revascularized either percutaneously or surgically, or had unreconstructable coronary artery disease. Mitral valve operation was performed when one grade higher than mild regurgitation was detected on the preoperative echocardiogram. Mitral valve procedures were concomitantly performed in 38 patients (52.8%), with 34 annuloplasty repairs, 3 edge-to-edge repairs, 10 and 1 replacement. Annuloplasty techniques varied over the course of the study and included a partial flexible annuloplasty band (Cosgrove ring, n=9, 26.5%), a complete flexible annuloplasty band (Duran ring, n=2, 5.9%) in the early period, and a semi-rigid complete annuloplasty ring (Carpentier-Edwards Physio ring, n=23, 67.6%) since 2003. Simultaneous LV assist system (LVAS) implantation was performed in 3 patients who presented in cardiogenic shock and had profound end-organ dysfunction. 7, 11 
Follow-up and Postoperative Evaluation
Follow-up was completed in 67 patients (93.1%) by telephone interview or review of the clinical record (mean follow-up 3.3±2.4 years). All of the cardiac and non-cardiac events were recorded. Early postoperative LV volumes and LVEF were assessed by either ventriculography or magnetic resonance imaging in 50 patients (69.4%). Data of postoperative right heart catheterization were available for 33 patients (45.8%). Post-LVR echocardiographic examinations were divided according to the time after surgery: early (<30 days after LVR) and late (at least 1 year after LVR); 71 patients (98.6%) underwent early echocardiographic examination, and 45 (64.3%) underwent late postoperative examination.
Statistical Analysis
SPSS version 11.0 (SPSS Inc, Chicago, IL, USA) software was used for statistical analysis. The quantitative data are presented as mean ± standard deviation. Values obtained from pre-and postoperative data were compared by pared t-test. The unpaired t-test was used to compare groups. The Kruskal-Wallis test and the 2 test were used to compare values among 3 groups. Calculation of survival and freedom from adverse events were performed by the Kaplan-Meier method. To clarify the independent variables of late survival, multivariate analysis (Cox proportional hazard model) was performed using variables with statistical significance in the univariate comparisons. Statistical significance was defined as p<0.05.
Results

Early and Late Clinical Outcomes
There were 2 deaths at 30 days (mortality 2.8%), which were related to ventricular tachycardia and progressive hepatic failure. Perioperative support by intra-aortic balloon pump and extra-corporeal life support were used in 14 (19.4%) and 2 (2.8%) patients, respectively. The use of intra-aortic balloon pump was relatively frequent because of the prophylactic use at the time of the operation. The LVAS was newly implanted in 2 patients in the early postoperative period. Therefore, a total of 5 patients required LVAS support. Ventricular tachyarrhythmia was recorded in 11 patients (15.3%); 6 patients (8.3%) underwent implantation of a cardioverter defibrillator in the early postoperative period.
During the follow-up period, a total of 16 patients died of congestive heart failure (n=3), ventricular tachyarrhythmia (n=2), sudden death (n=5), sepsis (n=2), acute MI (n=2), renal failure (n=1) or cerebral hemorrhage (n=1). Among the survivors, 2 patients who required LVAS support underwent heart transplantation at 958 and 1,247 days after the initial surgery. The overall actuarial survival rate at 1, 3, 5 years was 95.3%, 80.4% and 71.0%, respectively (Fig 1a) .
Pre-and intra-operative variables that had statistical significance for survival by univariate comparison were advanced NYHA class (IV), triple vessel disease, prolonged cardiopulmonary bypass time, requirement of mitral valve procedure, LV diastolic dimension >70 mm, and LV enddiastolic volume index (EDVI) >150 ml/m 2 . Although LV diastolic dimension and LVEDVI are continuous variables, a bifurcation into less or greater than 70 mm and 150 ml/m 2 was particularly significant as a determinant of prognosis. The type of LVR and preoperative LVEF did not affect survival (Figs 1b,c). Multivariate analysis was performed to identify the risk factors that affected survival. Cox-proportional hazard analyses showed that the pre-and intraoperative factors that significantly affected survival at risk included LV diastolic dimension >70 mm (odds ratio (OR) 7.4, p=0.015), and requirement of mitral valve procedures (OR 12.3, p=0.017) ( Table 3 ). Patients who required mitral valve procedures had significantly worse preoperative LV function and hemodynamic variables than those who did not ( Table 4 ). Major adverse cardiac events (MACE), including cardiovascular death (n=3), recurrence of congestive heart failure (n=13), MI or angina pectoris (n=4), ventricular tachycardia (n=4) and heart transplantation (n=2), occurred in 25 patients (34.7%). Freedom from MACE at 1, 3, and 5 years was 89.9%, 61.1%, and 48.4%, respectively, and freedom from readmission to hospital because of congestive heart failure at 1, 3, and 5 years was 91.5%, 75.5%, and 71%, respectively (Fig 1d) .
In most of the survivors, symptomatic improvements were noted in the late period. NYHA functional class significantly improved from 2.9±0.9 to 1.6±0.7 (p<0.0001); 90% of patients were in NYHA functional class I or II (Fig 2) .
LV Reverse Remodeling and Change in Mitral Regurgitation
At the early post-LVR examination, mean LVEF had significantly increased to 39±11 (p<0.0001; mean increase 14±0.6%). Postoperatively, LVEDVI (93±30 ml/m 2 ) and LVESVI (59±25 ml/m 2 ) significantly decreased (p<0.0001 for each). Mean PAP significantly decreased to 23± 8.6 mmHg (p=0.03), although postoperative PCWP (17± 6.6 mmHg) and CI (2.6±0.6 L· min -1 · m -2 ) did not show significant change after the operation.
Results of the late echocardiographic study (3.2±2.2 years after surgery) are shown in Table 5 . The improvement in LV dimensions and LVEF was still significant at the late study. The degree of mitral regurgitation had significantly decreased following LVR and mitral valve operation (p< 0.0001). The incidence of significant mitral regurgitation (moderate to severe) decreased from 34.7% preoperatively to 5.6% postoperatively. However, the latest degree of mitral regurgitation had significantly increased when compared with the data from the early study (0.4±0.9 vs 1.1± 1.3, p=0.02). There were 9 of 45 patients (20%) who showed greater than mild mitral regurgitation in the late period and these patients had a significantly higher incidence of previous inferoposterior MI (p=0.02) and a greater degree of preoperative mitral regurgitation (p=0.0009). Among those 9 patients, 4 had less than mild mitral regurgitation preoperatively, so no mitral procedure had been performed. Partial or flexible bands were used for mitral annuloplasty in the other 5 patients.
Discussion
This study demonstrated our group experience of LVR for patients with depressed cardiac function and dilated LV subsequent to MI. Our major findings are as follows. (1) LVR can be safely performed with an acceptable early mor- 
Early and Long-Term Results
The largest recent single-center experience published by Menicanti et al showed 4.7% of early mortality and 10-year survival of 63% in their cohort of 1,161 patients. 4 The most comprehensive analyses from a large multicenter study (RESTORE group) reported overall 30-day mortality of 5.3% and 5-year survival of 68.6%. 3 Excellent single-center early and long term results of LVR have been published by Suma's group. 8, 12 Our study showed low early mortality of 2.8% and a 5-year survival of 71%, which are comparable results to those from the previous studies. 3, 4, 8, 12 Moreover, the significant improvement in NYHA functional class continued in the late period and was also reflected in a satisfactory freedom from hospital admission associated with recurrent heart failure.
In the cohort of the RESTORE group study, mean preoperative LVESVI and LVEF were 80 ml/m 2 and 30%, respectively. Furthermore, they concluded that preoperative LVEF <30%, LVESVI >80 ml/m 2 , and advanced NYHA functional class were risk factors for death. 3 In our population, most patients (69%) were in NYHA functional class III or IV, including 14% of patients with cardiogenic shock, and preoperative LV dysfunction was remarkable with a mean preoperative LVEF of 25% and LVESVI of 111 ml/m 2 . Although the study population included relatively high-risk patients, our results demonstrated encouraging early and long-term results.
Conversely, our results may indicate the requirement for earlier surgical intervention before excessive LV remodeling and consequent mitral regurgitation develops. In our series, factors associated with adverse outcome included LV diastolic dimension >70 mm and requirement of mitral valve procedures. Patients in these categories had significant LV remodeling, which resulted in progressive ischemic mitral regurgitation (Table 4 ). Despite aggressive surgical approaches, these factors carry worse operative risks and long-term prognosis. 4, [13] [14] [15] We believe that early surgical intervention may attenuate LV remodeling and its deleterious effects on symptoms and survival.
LV Reverse Remodeling
Theoretical benefits of LVR are reducing wall stress and oxygen consumption by resecting the akinetic or dyskinetic scar and reshaping the spherical LV to a more elliptical shape, which induces improvement of pump function and LV reverse remodeling. 16 We found a significant decrease in the LV volumes immediately after operation. The average increase in LVEF of 14±0.6% is also comparable with results from other series. 3, 4, 8, 12 Unfortunately, reliable information in the long-term period was only available with echocardiographic parameters in a limited number of patients. However, there was a decrease in chamber dimensions and increased LVEF, and these improvements were still significant at 3 years after the operation. The effectiveness of LVR in ischemic cardiomyopathy for late LV reverse remodeling has been also reported in other series. 3, 4, 8, 12, 13 Sustained positive changes after LVR may contribute to the continued improvement of functional status and the decrease in recurrent congestive heart failure.
At present, the influence of medical treatments and concomitant surgical procedures, such as CABG and mitral valve surgery, remain unresolved because of the lack of randomized studies. The majority of our study population received postoperative medical treatment, including angiotensin-converting enzyme inhibitors, aldosterone antagonists, and -blockers. Furthermore, more than half of the patients underwent concomitant CABG and mitral valve surgery, which may have had a positive impact on our results in terms of LV reverse remodeling and systolic improvement. Even still, we agree with Menicanti et al that LVR may not only reverse the remodeling process but also make the heart more responsive to medical treatments, once its dimensions and geometry have improved. 4 Moreover, several reports have suggested that the effect of CABG with or without mitral valve surgery in patients with extensive ventricular remodeling is limited in terms of reverse remodeling. 17, 18 Our patients had extensively dilated left ventricles with anterior myocardial scarring. Consequently, we think that CABG and/or mitral valve operation is not sufficient and LVR is feasible when we aim for significant improvements of LV function.
Ischemic Mitral Regurgitation
Ischemic mitral regurgitation is frequently associated with post-ischemic LV dilatation and a worse prognosis. 19 Therefore, its surgical management has been extensively discussed, but is still problematic and controversial. In particular, recurrence of mitral regurgitation after ring annuloplasty is considered a major limitation of the current surgical Dor- strategy. 20 Although several different techniques have been reported to resolve this problem, such as papillary muscle imbrication 13 and edge to edge repair, 10 there is no consensus for when and how to correct ischemic mitral regurgitation in conjunction with LVR. The majority of the present patients underwent downsizing annuloplasty, as recommended by Bolling et al. 21 Besides the problem of recurrence of mitral regurgitation, the exact impact of this procedure on survival is also still debated, because recent studies reported that this procedure does not significantly improve long-term survival when compared with medical management or isolated CABG. 22, 23 In our study, the patients requiring mitral valve procedures had significantly worse survival than those without mitral valve procedures, despite the significant reduction of mitral regurgitation postoperatively. This suggests that fundamental ventricular pathology, rather than mitral regurgitation itself, may be the major limiting factor for survival.
In the present study population, recurrence of significant mitral regurgitation occurred in 20% of patients in the late period. These patients had a higher incidence of previous inferoposterior MI and a significant preoperative grade of mitral regurgitation. Local deformation of the inferoposterior wall has been reported as a trigger of leaflet tethering before and after LVR. 24 Mitral annular dilatation, papillary muscle displacement, and leaflet tethering associated with global and local LV remodeling subsequent to both anterior and inferior MI might impose substantial risk on the late recurrence of mitral regurgitation. Although anterior reconstruction by LVR can favorably change the LV geometric abnormalities causing ischemic mitral regurgitation by reducing ventricular volume and reshaping the global LV shape, 13, 25 further understanding of mitral valve geometry and local LV abnormalities is required to prevent the recurrence of mitral regurgitation in such high-risk patients.
Concerning the annuloplasty technique, we have introduced stringent downsizing annuloplasty, using the complete semi-rigid ring (Physio ring 24 or 26 mm), since 2003. Most recently, Braun et al reported the low recurrence of mitral regurgitation and survival benefits during a mean of 4-year follow-up after stringent downsizing annuloplasty. 18 Although their study population did not include patients who underwent concomitant LVR, this technical modification might have a positive impact on the outcome of patients requiring mitral valve surgery. Future investigations are required to examine the role of stringent downsizing annuloplasty in conjunction with LVR.
Study Limitations
Our study is limited by its retrospective analysis, a small patient cohort, and the lack of a control group. Moreover, our cohort included various diseased patients, from those with relatively stable heart failure symptoms to those with cardiogenic shock and from those with dyskinetic LV to a broadly akinetic one. Further investigations are required to clarify the effects of LVR on each category of patients.
Another limitation is the variety of surgical procedures used because of the nature of a multicenter cohort study. The choice of LVR depended on the surgeon's preference and era. However, LVR is still not a standard technique. Caldeira and McCarthy use a double purse-string suture technique without a patch. 26 Mickleborough et al reported the efficacy of linear closure and septoplasty. 27 Isomura et al demonstrated the superiority of the SAVE procedure in terms of obtaining a more ellipsoid LV shape. 8 In our study, the choice of LVR procedure did not affect the results, although the pre-and intraoperative characteristics were similar among the 3 groups ( Table 6 ). The optimal choice remains to be investigated.
Drug regimens and use of adjunctive medical device therapy (ie, biventricular pacing, implantable defibrillator) were also not standardized. For instance, we saw 15% of patients with postoperative ventricular tachycardia. Routine use of such medical devices might result in a better prognosis.
Conclusion
LVR can be performed with a low operative mortality and provide a satisfactory long-term survival by restoring the dilated LV and improving systolic function. Our study results suggest that LVR could be a choice of treatments in patients with depressed LV function after anterior MI. The role of concomitant mitral valve procedures in those with ischemic mitral regurgitation and excessive LV remodeling requires further investigation.
